<p style="text-align: justify;">Santiago de Cuba, Feb 26 (Prensa Latina) The Cuban medication Heberprot-P for diabetic feet ulcers is becoming increasingly accepted in a number of countries, according to Dr. Luis Herrera Martinez, director of the Genetic Engineering and Biotechnology Center CIGB).Herrera Martinez said Heberprot-P is the leading product of that institution, and it has been used to treat more than 22,000 patients in different countries, helping to avoid amputations and improve quality of life.
Read More